Report Detail

Pharma & Healthcare Global Pegfilgrastim Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2776834
  • |
  • 17 January, 2019
  • |
  • Global
  • |
  • 108 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils).

Scope of the Report:
The worldwide market for Pegfilgrastim is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Pegfilgrastim in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Amgen
Mylan
Coherus BioSciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Pegfilgrastim
Pegfilgrastim Biosimilar

Market Segment by Applications, can be divided into
Hospital
Drug store

There are 15 Chapters to deeply display the global Pegfilgrastim market.
Chapter 1, to describe Pegfilgrastim Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pegfilgrastim, with sales, revenue, and price of Pegfilgrastim, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pegfilgrastim, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pegfilgrastim market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pegfilgrastim sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

    1 Market Overview

    • 1.1 Pegfilgrastim Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Pegfilgrastim
      • 1.2.2 Pegfilgrastim Biosimilar
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Drug store
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Amgen
      • 2.1.1 Business Overview
      • 2.1.2 Pegfilgrastim Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Amgen Pegfilgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 Mylan
      • 2.2.1 Business Overview
      • 2.2.2 Pegfilgrastim Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Mylan Pegfilgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 Coherus BioSciences
      • 2.3.1 Business Overview
      • 2.3.2 Pegfilgrastim Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Coherus BioSciences Pegfilgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Pegfilgrastim Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Pegfilgrastim Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Pegfilgrastim Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Pegfilgrastim Manufacturer Market Share in 2017
      • 3.3.2 Top 6 Pegfilgrastim Manufacturer Market Share in 2017
    • 3.4 Market Competition Trend

    4 Global Pegfilgrastim Market Analysis by Regions

    • 4.1 Global Pegfilgrastim Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Pegfilgrastim Sales and Market Share by Regions (2013-2018)
      • 4.1.2 Global Pegfilgrastim Revenue and Market Share by Regions (2013-2018)
    • 4.2 North America Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 4.3 Europe Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 4.5 South America Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Pegfilgrastim Sales and Growth Rate (2013-2018)

    5 North America Pegfilgrastim by Countries

    • 5.1 North America Pegfilgrastim Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Pegfilgrastim Sales and Market Share by Countries (2013-2018)
      • 5.1.2 North America Pegfilgrastim Revenue and Market Share by Countries (2013-2018)
    • 5.2 United States Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 5.3 Canada Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 5.4 Mexico Pegfilgrastim Sales and Growth Rate (2013-2018)

    6 Europe Pegfilgrastim by Countries

    • 6.1 Europe Pegfilgrastim Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Pegfilgrastim Sales and Market Share by Countries (2013-2018)
      • 6.1.2 Europe Pegfilgrastim Revenue and Market Share by Countries (2013-2018)
    • 6.2 Germany Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 6.3 UK Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 6.4 France Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 6.5 Russia Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 6.6 Italy Pegfilgrastim Sales and Growth Rate (2013-2018)

    7 Asia-Pacific Pegfilgrastim by Countries

    • 7.1 Asia-Pacific Pegfilgrastim Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Pegfilgrastim Sales and Market Share by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Pegfilgrastim Revenue and Market Share by Countries (2013-2018)
    • 7.2 China Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 7.3 Japan Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 7.4 Korea Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 7.5 India Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 7.6 Southeast Asia Pegfilgrastim Sales and Growth Rate (2013-2018)

    8 South America Pegfilgrastim by Countries

    • 8.1 South America Pegfilgrastim Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Pegfilgrastim Sales and Market Share by Countries (2013-2018)
      • 8.1.2 South America Pegfilgrastim Revenue and Market Share by Countries (2013-2018)
    • 8.2 Brazil Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 8.3 Argentina Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 8.4 Colombia Pegfilgrastim Sales and Growth Rate (2013-2018)

    9 Middle East and Africa Pegfilgrastim by Countries

    • 9.1 Middle East and Africa Pegfilgrastim Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Pegfilgrastim Sales and Market Share by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Pegfilgrastim Revenue and Market Share by Countries (2013-2018)
    • 9.2 Saudi Arabia Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 9.3 UAE Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 9.4 Egypt Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 9.5 Nigeria Pegfilgrastim Sales and Growth Rate (2013-2018)
    • 9.6 South Africa Pegfilgrastim Sales and Growth Rate (2013-2018)

    10 Global Pegfilgrastim Market Segment by Type

    • 10.1 Global Pegfilgrastim Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Pegfilgrastim Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Pegfilgrastim Revenue and Market Share by Type (2013-2018)
    • 10.2 Pegfilgrastim Sales Growth and Price
      • 10.2.1 Global Pegfilgrastim Sales Growth (2013-2018)
      • 10.2.2 Global Pegfilgrastim Price (2013-2018)
    • 10.3 Pegfilgrastim Biosimilar Sales Growth and Price
      • 10.3.1 Global Pegfilgrastim Biosimilar Sales Growth (2013-2018)
      • 10.3.2 Global Pegfilgrastim Biosimilar Price (2013-2018)

    11 Global Pegfilgrastim Market Segment by Application

    • 11.1 Global Pegfilgrastim Sales Market Share by Application (2013-2018)
    • 11.2 Hospital Sales Growth (2013-2018)
    • 11.3 Drug store Sales Growth (2013-2018)

    12 Pegfilgrastim Market Forecast (2018-2023)

    • 12.1 Global Pegfilgrastim Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Pegfilgrastim Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Pegfilgrastim Market Forecast (2018-2023)
      • 12.2.2 Europe Pegfilgrastim Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Pegfilgrastim Market Forecast (2018-2023)
      • 12.2.4 South America Pegfilgrastim Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Pegfilgrastim Market Forecast (2018-2023)
    • 12.3 Pegfilgrastim Market Forecast by Type (2018-2023)
      • 12.3.1 Global Pegfilgrastim Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Pegfilgrastim Market Share Forecast by Type (2018-2023)
    • 12.4 Pegfilgrastim Market Forecast by Application (2018-2023)
      • 12.4.1 Global Pegfilgrastim Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Pegfilgrastim Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Pegfilgrastim . Industry analysis & Market Report on Pegfilgrastim is a syndicated market report, published as Global Pegfilgrastim Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Pegfilgrastim market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,756.16
      4,134.24
      5,512.32
      3,215.52
      4,823.28
      6,431.04
      526,489.20
      789,733.80
      1,052,978.40
      290,127.60
      435,191.40
      580,255.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report